loadpatents
Patent applications and USPTO patent grants for ORECCHIA; Martin Anibal.The latest application filed is for "biopharmaceutical compositions comprising antibody variants".
Patent | Date |
---|---|
Biopharmaceutical Compositions Comprising Antibody Variants App 20210115128 - AKINSEYE; Chika ;   et al. | 2021-04-22 |
Antigen-binding Constructs App 20160207993 - ASHMAN; Claire ;   et al. | 2016-07-21 |
Antigen-binding proteins Grant 9,394,374 - Hamblin , et al. July 19, 2 | 2016-07-19 |
IL-13 binding protein Grant 8,680,245 - Ashman , et al. March 25, 2 | 2014-03-25 |
Humanised Antigen Binding Proteins To Myostatin6 App 20130142788 - Ashman; Claire ;   et al. | 2013-06-06 |
Il-13 Binding Protein App 20120082682 - Ashman; Claire ;   et al. | 2012-04-05 |
Antigen-binding Proteins App 20120070439 - Hamblin; Paul Andrew ;   et al. | 2012-03-22 |
Myostatin Binding Proteins App 20110256132 - Ashman; Claire ;   et al. | 2011-10-20 |
Antigen-binding Constructs App 20110008345 - Ashman; Claire ;   et al. | 2011-01-13 |
Immunoglobulins App 20100303821 - ASHMAN; CLAIRE ;   et al. | 2010-12-02 |
Antigen-binding Constructs App 20090148905 - ASHMAN; Claire ;   et al. | 2009-06-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.